Detalhe da pesquisa
1.
Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.
J Pharmacol Sci
; 127(3): 362-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25837935
2.
Activation of the serotonin 5-HT2C receptor is involved in the enhanced anxiety in rats after single-prolonged stress.
Pharmacol Biochem Behav
; 89(1): 11-6, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18067955
3.
Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia.
Eur Neuropsychopharmacol
; 28(5): 620-629, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29571967
4.
Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Eur J Pharmacol
; 553(1-3): 171-84, 2006 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17074317
5.
ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia.
Eur Neuropsychopharmacol
; 24(10): 1698-708, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108314
6.
4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.
J Med Chem
; 56(9): 3582-92, 2013 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23566269
7.
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Eur J Pharmacol
; 685(1-3): 59-69, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22542656
8.
Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Behav Brain Res
; 216(2): 561-8, 2011 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20816897
9.
Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
Life Sci
; 88(17-18): 761-5, 2011 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21356217
10.
[Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia].
Nihon Yakurigaku Zasshi
; 136(3): 128-32, 2010 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-20838012
11.
Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors.
J Pharmacol Sci
; 96(1): 42-52, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15351792